← back to search

Kan Lu

Guangxi University · CN
Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Lung Cancer Treatments and Mutations, and Cell Adhesion Molecules Research.
h-index
28
citations
6,569
works
85
NIH funding
primary concept
email

Recent publications

Intense photoluminescence across wavelengths from ultraviolet to NIR-II in Yb3+/Er3+ co-doped cubic HfO2 single crystals with ultra-high melting point excited at 980 nm
Ceramics International 2025cited by 5position: middledoi
NIR laser irradiation of Er<sub>0.5</sub>Yb<sub>2.5</sub>Al<sub>5</sub>O<sub>12</sub> single crystal: photoluminescence from ultraviolet to NIR-II
CrystEngComm 2025cited by 3position: middledoi
Effect of Y3+ Doping on Microstructure and Magnetic Transition of CuCrO2 Ceramics
Materials 2025cited by 2position: middledoi
Design, growth and photoluminescence properties of Yb3+:ErSZ and Er3+:YbSZ single crystals excited by 1550 nm and 980 nm lasers
Optical Materials 2024cited by 7position: middledoi
Highly efficient ultraviolet and visible light emissions from upconversion transitions in Ho/Tm/Yb co-doped lutecia-stabilized zirconia single crystals excited by a 980 nm laser
CrystEngComm 2024cited by 5position: firstdoi
A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma
Nature Cell Biology 2018cited by 175position: middledoi
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Proceedings of the National Academy of Sciences 2017cited by 81position: middledoi
Abstract PR05: Glycoprotein-mediated tissue mechanics regulate glioblastoma aggression
Cancer Research 2017cited by 0position: middledoi
Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management
American Journal of Transplantation 2015cited by 243position: middledoi
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Cancer Cell 2012cited by 554position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Wen Deng · Guangxi University5 papers (2024–2025)Wenxia Wu · Guangxi University4 papers (2024–2025)Gabriele Bergers · VIB-KU Leuven Center for Cancer Biology4 papers (2012–2018)Shoulei Xu · Guangxi University4 papers (2024–2025)Juan Kong · Guangxi University4 papers (2024–2025)Qifan Zhang · Guangxi University4 papers (2024–2025)Yan Hao · Guangxi University4 papers (2024–2025)Haibo Lin · Guangxi University2 papers (2024–2025)Yazhao Wang · Guangxi University2 papers (2024–2024)Joanna J. Phillips · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2012–2018)Valerie M. Weaver · University of California, San Francisco2 papers (2017–2018)J. Matthew Barnes · AbbVie (United States)2 papers (2017–2018)Elliot C. Woods · Broad Institute2 papers (2017–2018)Manish K. Aghi · Pediatric Brain Tumor Foundation2 papers (2012–2017)Zhaoyue Wang · Guangxi University2 papers (2025–2025)Carolyn R. Bertozzi · Stanford University2 papers (2017–2018)Russell Bainer · Maze (United States)2 papers (2017–2018)Yuyang Huang · South China Agricultural University2 papers (2025–2025)Dingkang Xiong · Guangxi University2 papers (2025–2025)Guozhu Xiong · Guangxi University1 papers (2025–2025)